Bioequivalence Assessment Between Two Cariprazine Hard Capsule Formulations
Status:
COMPLETED
Trial end date:
2025-01-23
Target enrollment:
Participant gender:
Summary
An open label, randomized, single-dose, two sequence, two-period, crossover study to assess the bioequivalence of Cariprazine in Vocarzine 1.5 mg hard gelatin capsule (Test product) in comparison with Reagila 1.5 mg hard capsules (Reference product) in 30 healthy subjects under fasting conditions
Phase:
PHASE1
Details
Lead Sponsor:
Aya Mohammed Abdel Magid Abdel Hamid
Collaborators:
Advanced Research Center (ARC) Atco Pharma for Pharmaceutical Industries